Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
Status:
Not yet recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
For many years there is a lack of large randomized controlled trials that study the effect of
low dose prednisone in women with RPL and thus the evidence of a probable efficacy of
prednisone in RPL women remains limited and unclear. As the ESHRE recommended in 2018 (2) we
aim to assess the effect of such treatment in a large trial that includes unexplained and
abnormal autoimmune profile RPL patients. we also aim to assess the side effects of the
treatment in RPL pregnant women.